Abstract
Thiazides are widely used in the prevention of calcific urinary calculi, as they reduce the urinary excretion of calcium and the stone recurrence rate1. In an attempt to separate specific from non-specific effects of thiazide treatment we undertook a double blind study using hydrochlorothiazide or placebo for over one year in patients with recurrent calcium lithiasis.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
E. R. Yendt, F. G. Guay, and D. A. Garcia, Can. Med. Assoc. J. 102:614 (1970).
L. H. Smith, Urol. Clin. N. Am. 1:241 (1974).
D. A. Garcia and E. R. Yendt, Can. Med. Assoc. J. 103:473 (1970).
W. G. Robertson and B. E. C. Nordin, in: “Renal Stone Research Symposium,” A. Hodgkinson and B. E. C. Nordin, ed., Churchill, London (1969).
E. R. Yendt, R. J. A. Gagne, and M. Cohanim, Trans. Am. Clin. Climatol. Assoc. 77:96 (1965).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1981 Springer Science+Business Media New York
About this chapter
Cite this chapter
Scholz, D., Schwille, P.O., Sigel, A. (1981). Experiences with Thiazides in a Double Blind Study. In: Smith, L.H., Robertson, W.G., Finlayson, B. (eds) Urolithiasis. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-8977-4_41
Download citation
DOI: https://doi.org/10.1007/978-1-4684-8977-4_41
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-8979-8
Online ISBN: 978-1-4684-8977-4
eBook Packages: Springer Book Archive